Terminal Onset Diabetes Insipidus with Candidiasis Majeure

This longitudinal clinical case study documents the trajectory of a single subject from birth on July 5, 1969 through the Stage 5 physiological threshold crossed on January 17, 2022, a period of approximately 52.5 years encompassing disrupted developmental onboarding, four iatrogenic perturbation events, and four architectural transitions of the endocrine-vascular system. The subject and author are the same individual. The framework applied is the biochemical computer model articulated in Paper A (Craddock, 10.5281/zenodo.19337525), extended by the Saline Oscillation Hypothesis in Paper B (Craddock, 10.5281/zenodo.19369715).

The case is reported using primary-source institutional laboratory and imaging records retained in the electronic medical record, supplemented where necessary by contemporaneous patient-prepared documentation and photographic evidence. Four sections organize the arc. Section I covers birth through the Silent Loss Phase to 2008, including disrupted breastfeeding onboarding, infantile phenobarbital exposure, the age-14 phenobarbital ulceration event, and the 1995 Donnatal cascade with the Norman bathroom bearing-down event that established suction-dominant cardiac physiology. Section II covers the Stage 2 potassium threshold event of 2008 and the extended lead-in to the 2012 transition, including the November 2009 Tulsa Run dehydration, the August 2011 neuroendocrine workup documenting serum serotonin at less than half the lower reference limit and suppressed urine creatinine production, and the February 2010 Saint John's admission documenting plasma osmolality above reference. Section III covers the 2012 Stage 3 transition precipitated by CT-iodine contrast paired with protocol heparin, the subsequent Survival via Pituitary period including a pituitary microgranuloma finding on dedicated MRI, the August 2017 rib fracture at trivial mechanism, and the October 2018 colonoscopy documenting five tubular adenomas distributed across the colonic compartment. Section IV covers the February 2018 Stage 4 transition documented in companion case report (Craddock, 10.5281/zenodo.19462705), the post-transition hyperadrenergic period with its overflow-retrieval feeding mechanism, photographic documentation of organism-governed body composition across a seven-month interval, the COVID-era cholesterol trajectory running linearly at approximately 4 mg/dL per year across twelve years, and the six-factor 2021 decline cluster preceding the January 17, 2022 threshold.

A multigenerational observation thread is maintained throughout. The subject's maternal grandfather, present at the subject's birth and for much of his life thereafter, lived 101 years as a managed Homo candidus phenotype, providing the framework's clearest observational comparator for what organism-host co-management looks like when sustained without iatrogenic disruption. Stage 5 onward is documented in the companion case report (Craddock, 10.5281/zenodo.19560800).

Framework signatures documented across the institutional record include suppressed eosinophil and basophil populations during transition periods, persistently elevated urine specific gravity as baseline operating state, suppressed creatinine production with implications for eGFR interpretation, gallbladder ejection fractions in the hyperkinetic range, distributed gastrointestinal proliferative lesions post-transition (fundic gland polyps April 2018, five colonic tubular adenomas October 2018), and a linear twelve-year cholesterol trajectory compatible with the Wang et al. (2024) and Gaglione et al. (2021) mechanism of organism-mediated LDL-C elevation through formyl-methionine signaling and apolipoprotein B antifungal cryptide pathways. The case demonstrates that framework-predicted signatures are captured in routine institutional panels across decades, independent of any diagnostic framework capable of integrating them.